Search by Drug Name or NDC

NDC 69842-0220-50 SENNOSIDES 8.6 mg/1 Details

SENNOSIDES 8.6 mg/1

SENNOSIDES is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy, Inc.. The primary component is SENNOSIDES.

MedlinePlus Drug Summary

Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.

Related Packages: 69842-0220-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Senna

Product Information

NDC	69842-0220
Product ID	69842-220_c447ed19-7c43-22d2-e053-2a95a90aaae6
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	SENNOSIDES
Proprietary Name Suffix	n/a
Non-Proprietary Name	SENNOSIDES
Product Type	HUMAN OTC DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	8.6
Active Ingredient Units	mg/1
Substance Name	SENNOSIDES
Labeler Name	CVS Pharmacy, Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	OTC MONOGRAPH NOT FINAL
Application Number	part334
Listing Certified Through	2024-12-31

Package

Package Images

NDC 69842-0220-50 (69842022050)

Pricing Information	N/A
NDC Package Code	69842-220-50
Billing NDC	69842022050
Package	1 BOTTLE in 1 CARTON (69842-220-50) / 50 TABLET, FILM COATED in 1 BOTTLE
Marketing Start Date	2018-07-03
NDC Exclude Flag	N

Standard Product Labeling (SPL)/Prescribing Information SPL 6dffc3f5-bae0-c436-e053-2991aa0a0f8b Details

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6 mg

SPL UNCLASSIFIED SECTION

Laxative

Uses

relieves occasional constipation (irregularity)
generally produces a bowel movement in 6-12 hours

SPL UNCLASSIFIED SECTION

Do not use laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

stomach pain 
nausea 
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	starting dosage	maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

 each tablet contains: calcium 20 mg

 store in a dry place at 15° – 30°C (59° – 86°F)

SPL UNCLASSIFIED SECTION

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc

Questions or comments?

Call 1-877-753-3935 Monday - Friday 9AM-5PM EST

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

KEEP OUTER CARTON FOR COMPLETE WARNINGS AND PRODUCT INFORMATION.

*This product is not manufactured or distributed by Avrio Health L.P., marketer of Senokot®.

Distributed by: CVS Pharmacy, Inc.

One CVS Drive, Woonsocket, RI 02895

© 2021 CVS/pharmacy

CVS.com® 1-800-SHOP CVS

V-30287

PRINCIPAL DISPLAY PANEL

CVSHealth

Compare to the active ingredient in Senokot®*

Senna

SENNOSIDES, 8.6 mg

Laxative

Standardized senna concentrate

Natural vegetable laxative ingredient

50 TABLETS

INGREDIENTS AND APPEARANCE

SENNOSIDES

sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:69842-220
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)
HYPROMELLOSES (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
TALC (UNII: 7SEV7J4R1U)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	1122;1122
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:69842-220-25	250 in 1 BOTTLE; Type 0: Not a Combination Product	07/03/2018
2	NDC:69842-220-50	1 in 1 CARTON	07/03/2018
2		50 in 1 BOTTLE; Type 0: Not a Combination Product
3	NDC:69842-220-08	500 in 1 BOTTLE; Type 0: Not a Combination Product	04/29/2021

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph not final	part334	07/03/2018

Labeler - CVS Pharmacy, Inc. (062312574)

Revised: 6/2021

Document Id: c447ed19-7c43-22d2-e053-2a95a90aaae6

Set id: 6dffc3f5-bae0-c436-e053-2991aa0a0f8b

Version: 4

Effective Time: 20210621

Search by Drug Name or NDC

NDC 69842-0220-50 SENNOSIDES 8.6 mg/1 Details

SENNOSIDES 8.6 mg/1

MedlinePlus Drug Summary

Product Information

Package

Package Images

NDC 69842-0220-50 (69842022050)

Contents

Standard Product Labeling (SPL)/Prescribing Information SPL 6dffc3f5-bae0-c436-e053-2991aa0a0f8b Details

Drug Facts

SPL UNCLASSIFIED SECTION

Uses

SPL UNCLASSIFIED SECTION

Directions

Other information

SPL UNCLASSIFIED SECTION

Questions or comments?

SPL UNCLASSIFIED SECTION

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

Plavix (Clopidogrel) With Olive Oil Dosing Question

Can You Take A Z-Pak If You Have A Penicillin Allergy?